Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Chinese patients with hypertension evaluated the efficacy and safety of a single-pill fixed-dose combination of losartan and hydroch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan/Hydrochlorothiazide fixed-dose combination (losartan/hydrochlorothiazide)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Hypertension | Phase 4 | Status: COMPLETED